Citation Impact
Citing Papers
Place of Cabergoline in Acromegaly: A Meta-Analysis
2011
Tumor Volume of Growth Hormone-Secreting Pituitary Adenomas during Treatment with Pegvisomant: A Prospective Multicenter Study
2009
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century
2015 StandoutNobel
Guidelines for Acromegaly Management: An Update
2009
Effective Combination Treatment with Cabergoline and Low-Dose Pegvisomant in Active Acromegaly: A Prospective Clinical Trial
2012
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids
2005
Intensive versus conventional glycaemic control for treating diabetic foot ulcers
2016
Opioid analgesia: perspectives on right use and utility.
2007
Opioid Use for Noncancer Pain and Risk of Fracture in Adults: A Nested Case-Control Study Using the General Practice Research Database
2013
Drug-Related Side Effects of Long-termIntrathecal Morphine Therapy
2007
Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study
2008
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
2010 Standout
Acromegaly
2006 Standout
DHEAS Deficiency During Consumption of Sustained-Action Prescribed Opioids: Evidence for Opioid-Induced Inhibition of Adrenal Androgen Production
2006
Pegvisomant and cabergoline combination therapy in acromegaly
2012
Hypogonadism in men consuming sustained-action oral opioids
2002
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
2008 Standout
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Low Back Pain: From Algorithm to Cost‐Effectiveness?
2005
Bowel Disorders
2016 Standout
Diabetic Foot Ulcers and Their Recurrence
2017 Standout
Metabolic syndrome in people with schizophrenia: a review
2009
Opioid Endocrinopathy in Women Consuming Prescribed Sustained-Action Opioids for Control of Nonmalignant Pain
2007
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Clinical use of cabergoline as primary and adjunctive treatment for acromegaly
2008
Cushing's syndrome
2015 Standout
Exercise Standards for Testing and Training
2013 Standout
Growth Hormone Receptor Antagonists
2004
Preventing and treating foot complications associated with diabetes mellitus
2015
Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A−/−, 5-HT1B−/−, 5-HT2A−/−, 5-HT3A−/− and 5-HTT−/− knock-out male mice
2007 StandoutNobel
Effect of pegylation on pharmaceuticals
2003 Standout
Diagnosis and Treatment of Pituitary Tumors
1999
Cabergoline Decreases Somatotroph Adenoma Size: A Case Report
2004
Gamma knife radiosurgery for acromegaly – long‐term experience
2006
Opioid Therapy for Chronic Pain
2003
Primary medical therapy for acromegaly
2003
Raloxifene decreases serum IGF-I in male patients with active acromegaly
2004
Epidemiology of Acromegaly
1999
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
Elucidating Risk Factors for Androgen Deficiency Associated with Daily Opioid Use
2014
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Cabergoline Therapy of Growth Hormone & Growth Hormone/Prolactin Secreting Pituitary Tumors
2004
Central and peripheral actions of somatostatin on the growth hormone–IGF-I axis
2004
Physical Activity Advice Only or Structured Exercise Training and Association With HbA1cLevels in Type 2 Diabetes
2011
Sex differences in pain and analgesia: the role of gonadal hormones
2004
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings
2009 Standout
Mechanistic insight into diabetic wounds: Pathogenesis, molecular targets and treatment strategies to pace wound healing
2019 Standout
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment
2010 Standout
ROS-scavenging hydrogel to promote healing of bacteria infected diabetic wounds
2020 Standout
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
2009 Standout
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
The Association Between Obesity and Low Back Pain: A Meta-Analysis
2009 Standout
Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin status
2004
A systematic review of low back pain cost of illness studies in the United States and internationally
2008 Standout
Management of Schizophrenia with Obesity, Metabolic, and Endocrinological Disorders
2009
Impact of different training modalities on glycaemic control and blood lipids in patients with type 2 diabetes: a systematic review and network meta-analysis
2014
Dopamine Receptor Expression and Function in Corticotroph Pituitary Tumors
2004
Effects of supervised exercise on lipid profiles and blood pressure control in people with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials
2012
Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale Study, a prospective cohort study
2008
Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation
2010
Augmentation of diabetic wound healing and enhancement of collagen content using nanofibrous glucophage-loaded collagen/PLGA scaffold membranes
2014
Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids
2004
Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study
2008
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
2015 Standout
Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy
2003
Cushing's syndrome
2006 Standout
Open-Label Pilot Study of Testosterone Patch Therapy in Men With Opioid-Induced Androgen Deficiency
2006
Opioid-Induced Endocrinopathy in Cancer Patients: An Underestimated Clinical Problem
2014
Herpes Zoster
2013 Standout
Opioids in chronic non-cancer pain: systematic review of efficacy and safety
2004
Guidelines for Acromegaly Management
2002
Psychosocial Stress and Psychosis. A Review of the Neurobiological Mechanisms and the Evidence for Gene-Stress Interaction
2008
The Complex Role of Estrogens in Inflammation
2007 Standout
Pituitary Lactotroph Adenomas Develop after Prolonged Lactotroph Hyperplasia in Dopamine D2 Receptor-Deficient Mice1
1999
Update on management of diabetic foot ulcers
2018 Standout
Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly
2002
Opioids versus antidepressants in postherpetic neuralgia
2002
The impact of the multidisciplinary team in the management of individuals with diabetic foot ulcers: a systematic review
2017
Optimizing Control of Acromegaly: Integrating a Growth Hormone Receptor Antagonist into the Treatment Algorithm
2003
Control of growth hormone and IGF 1 in patients with acromegaly in the UK : responses to medical treatment with somatostatin analogues and dopamine agonists
2013
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
2015 Standout
Suppression of Rat and Human Growth Hormone and Prolactin Secretion by a Novel Somatostatin/Dopaminergic Chimeric Ligand
2003
Criteria for Cure of Acromegaly: A Consensus Statement
2000
Approach to the Patient with Persistent Acromegaly after Pituitary Surgery
2010
Pharmacology of Penile Erection
2001
Cabergoline in the Treatment of Hyperprolactinemia: A Study in 455 Patients
1999
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Opioid use for noncancer pain and risk of myocardial infarction amongst adults
2013
Opioids in the Management of ChronicNon-Cancer Pain: An Update of AmericanSociety of the Interventional Pain Physicians’(ASIPP) Guidelines
2008
Successful treatment of resistant acromegaly with a growth hormone receptor antagonist
2001
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
The Daily Rhythm in Plasma Glucagon Concentrations in the Rat Is Modulated by the Biological Clock and by Feeding Behavior
2003
Insulin sensitivity and glucose tolerance improve in patients with acromegaly converted from depot octreotide to pegvisomant
2003
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Opioid Prescriptions for Chronic Pain and Overdose
2010 Standout
Long-Acting Peptidomimergic Control of Gigantism Caused by Pituitary Acidophilic Stem Cell Adenoma*
2000
Effects of Exercise on Cardiovascular Risk Factors in Type 2 Diabetes
2011
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association
2016 Standout
The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop
2015 Standout
Acromegaly: historical perspectives and current therapy
2001
Long-term opioid management for chronic noncancer pain
2010
Demonstration of Enhanced Potency of a Chimeric Somatostatin-Dopamine Molecule, BIM-23A387, in Suppressing Growth Hormone and Prolactin Secretion from Human Pituitary Somatotroph Adenoma Cells
2002
Biomedical Importance of Indoles
2013 Standout
A Critical Analysis of Pituitary Tumor Shrinkage during Primary Medical Therapy in Acromegaly
2005
Opioid Complications and Side Effects
2008 Standout
Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
Anatomy, Physiology, and Pathophysiology of Erectile Dysfunction
2010
Diabetic foot infection: Antibiotic therapy and good practice recommendations
2017
The Effects of Opioids and Opioid Analogs on Animal and Human Endocrine Systems
2009
Opioid Guidelines in the Management ofChronic Non-Cancer Pain
2006
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly-2011 Update
2011
Works of Kristien Van Acker being referenced
Health-Related Quality of Life Predicts Major Amputation and Death, but Not Healing, in People With Diabetes Presenting With Foot Ulcers: The Eurodiale Study
2013
The effectiveness of text messages support for diabetes self-management: protocol of the TEXT4DSM study in the democratic Republic of Congo, Cambodia and the Philippines
2013
Endocrine Consequences of Long-Term Intrathecal Administration of Opioids
2000
The German and Belgian accreditation models for diabetic foot services
2015
Cabergoline in the Treatment of Acromegaly: A Study in 64 Patients
1998
Optimal Organization of Health Care in Diabetic Foot Disease: Introduction to the Eurodiale Study
2007
Predictors of Lower-Extremity Amputation in Patients With an Infected Diabetic Foot Ulcer
2015
Influence of combined exercise training on indices of obesity, diabetes and cardiovascular risk in type 2 diabetes patients
2008
Importance of glucagon as a determinant of resting metabolic rate and glucose-induced thermogenesis in obese women
1991
Burden of diabetic foot disorders, guidelines for management and disparities in implementation in Europe: a systematic literature review
2014